PENTOBARBITAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pentobarbital, and what generic alternatives are available?
Pentobarbital is a drug marketed by Lannett, Vitarine, Whiteworth Town Plsn, Bpi Labs, Elkins Sinn, Hikma, and Sagent Pharms Inc. and is included in nine NDAs.
The generic ingredient in PENTOBARBITAL is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentobarbital
A generic version of PENTOBARBITAL was approved as pentobarbital sodium by SAGENT PHARMS INC on May 23rd, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENTOBARBITAL?
- What are the global sales for PENTOBARBITAL?
- What is Average Wholesale Price for PENTOBARBITAL?
Summary for PENTOBARBITAL
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 9 |
| Drug Prices: | Drug price information for PENTOBARBITAL |
| DailyMed Link: | PENTOBARBITAL at DailyMed |
Recent Clinical Trials for PENTOBARBITAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sohag University | Phase 2/Phase 3 |
| Assiut University | N/A |
| Children's Hospital Medical Center, Cincinnati | Phase 1 |
Medical Subject Heading (MeSH) Categories for PENTOBARBITAL
Anatomical Therapeutic Chemical (ATC) Classes for PENTOBARBITAL
US Patents and Regulatory Information for PENTOBARBITAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | PENTOBARBITAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 085937-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | PENTOBARBITAL SODIUM | pentobarbital sodium | INJECTABLE;INJECTION | 203619-001 | Nov 13, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Whiteworth Town Plsn | PENTOBARBITAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 083338-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
